98 related articles for article (PubMed ID: 25354842)
1. Specific dephosphorylation of Janus Kinase 2 by protein tyrosine phosphatases.
Li J; Liu X; Chu H; Fu X; Li T; Hu L; Xing S; Li G; Gu J; Zhao ZJ
Proteomics; 2015 Jan; 15(1):68-76. PubMed ID: 25354842
[TBL] [Abstract][Full Text] [Related]
2. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.
Feng J; Witthuhn BA; Matsuda T; Kohlhuber F; Kerr IM; Ihle JN
Mol Cell Biol; 1997 May; 17(5):2497-501. PubMed ID: 9111318
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases.
Lee JK; Edderkaoui M; Truong P; Ohno I; Jang KT; Berti A; Pandol SJ; Gukovskaya AS
Gastroenterology; 2007 Nov; 133(5):1637-48. PubMed ID: 17983808
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, characterization and crystallization of non- and phosphorylated states of JAK2 and JAK3 kinase domain.
Hall T; Emmons TL; Chrencik JE; Gormley JA; Weinberg RA; Leone JW; Hirsch JL; Saabye MJ; Schindler JF; Day JE; Williams JM; Kiefer JR; Lightle SA; Harris MS; Guru S; Fischer HD; Tomasselli AG
Protein Expr Purif; 2010 Jan; 69(1):54-63. PubMed ID: 19781647
[TBL] [Abstract][Full Text] [Related]
5. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
6. Assay of protein tyrosine phosphatases by using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Chen J; Qi Y; Zhao R; Zhou GW; Zhao ZJ
Anal Biochem; 2001 May; 292(1):51-8. PubMed ID: 11319817
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
9. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.
Kovalenko M; Denner K; Sandström J; Persson C; Gross S; Jandt E; Vilella R; Böhmer F; Ostman A
J Biol Chem; 2000 May; 275(21):16219-26. PubMed ID: 10821867
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B.
Choi JH; Kim HS; Kim SH; Yang YR; Bae YS; Chang JS; Kwon HM; Ryu SH; Suh PG
Nat Cell Biol; 2006 Dec; 8(12):1389-97. PubMed ID: 17128263
[TBL] [Abstract][Full Text] [Related]
12. Src kinase regulation by phosphorylation and dephosphorylation.
Roskoski R
Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
[TBL] [Abstract][Full Text] [Related]
13. Roles of JAK kinase in human GM-CSF receptor signals.
Watanabe S; Itoh T; Arai K
Leukemia; 1997 Apr; 11 Suppl 3():76-8. PubMed ID: 9209304
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase receptor type γ is a JAK phosphatase and negatively regulates leukocyte integrin activation.
Mirenda M; Toffali L; Montresor A; Scardoni G; Sorio C; Laudanna C
J Immunol; 2015 Mar; 194(5):2168-79. PubMed ID: 25624455
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Janus kinase 2 by p53 in ovarian cancer cells.
Reid T; Jin X; Song H; Tang HJ; Reynolds RK; Lin J
Biochem Biophys Res Commun; 2004 Aug; 321(2):441-7. PubMed ID: 15358195
[TBL] [Abstract][Full Text] [Related]
16. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
17. Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase.
Rocchi S; Gaillard I; van Obberghen E; Chambaz EM; Vilgrain I
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):483-90. PubMed ID: 11085942
[TBL] [Abstract][Full Text] [Related]
18. Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation.
McDoom I; Ma X; Kirabo A; Lee KY; Ostrov DA; Sayeski PP
Biochemistry; 2008 Aug; 47(32):8326-34. PubMed ID: 18636744
[TBL] [Abstract][Full Text] [Related]
19. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase.
Lee JP; Cho H; Bannwarth W; Kitas EA; Walsh CT
Protein Sci; 1992 Oct; 1(10):1353-62. PubMed ID: 1303753
[TBL] [Abstract][Full Text] [Related]
20. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
